✦ LIBER ✦

Discovery of a New Class of Potent, Selective, and Orally Bioavailable CRTH2 (DP2) Receptor Antagonists for the Treatment of Allergic Inflammatory Diseases #

✍ Scribed by Crosignani, Stefano; Page, Patrick; Missotten, Marc; Colovray, Véronique; Cleva, Christophe; Arrighi, Jean-François; Atherall, John; Macritchie, Jackie; Martin, Thierry; Humbert, Yves; Gaudet, Marilène; Pupowicz, Doris; Maio, Maurizio; Pittet, Pierre-André; Golzio, Lucia; Giachetti, Claudio; Rocha, Cynthia; Bernardinelli, Gérald; Filinchuk, Yaroslav; Scheer, Alexander; Schwarz, Matthias K.; Chollet, André

Book ID: 121363802
Publisher: American Chemical Society
Year: 2008
Tongue: English
Weight: 717 KB
Volume: 51
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm701383e

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discovery of Potent and Orally Bioavaila

Discovery of Potent and Orally Bioavailable N,N′-Diarylurea Antagonists for the CXCR2 Chemokine Receptor.

✍ Qi Jin; et al. et al. 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 21 KB 👁 2 views

Discovery and Development of a New Class

Discovery and Development of a New Class of Potent, Selective, Orally Active Oxytocin Receptor Antagonists

✍ Quattropani, Anna; Dorbais, Jérôme; Covini, David; Pittet, Pierre-André; Colovra 📂 Article 📅 2005 🏛 American Chemical Society 🌐 English ⚖ 444 KB

Discovery of MK-7246, a selective CRTH2

Discovery of MK-7246, a selective CRTH2 antagonist for the treatment of respiratory diseases

✍ Michel Gallant; Christian Beaulieu; Carl Berthelette; John Colucci; Michael A. C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 567 KB

In this manuscript we wish to report the discovery of MK-7246 (4), a potent and selective CRTH2 (DP2) antagonist. SAR studies leading to MK-7246 along with two synthetic sequences enabling the preparation of this novel class of CRTH2 antagonist are reported. Finally, the pharmacokinetic and metaboli

ChemInform Abstract: Discovery of MK-724

ChemInform Abstract: Discovery of MK-7246, a Selective CRTH2 Antagonist for the Treatment of Respiratory Diseases.

✍ Michel Gallant; et al. et al. 📂 Article 📅 2011 🏛 John Wiley and Sons ⚖ 21 KB 👁 1 views

Discovery of a Potent, Selective, and Or

Discovery of a Potent, Selective, and Orally Active Human Epidermal Growth Factor Receptor-2 Sheddase Inhibitor for the Treatment of Cancer†

✍ Yao, Wenqing; Zhuo, Jincong; Burns, David M.; Xu, Meizhong; Zhang, Colin; Li, Yu 📂 Article 📅 2007 🏛 American Chemical Society 🌐 English ⚖ 79 KB

The Discovery and Optimization of a Nove

The Discovery and Optimization of a Novel Class of Potent, Selective, and Orally Bioavailable Anaplastic Lymphoma Kinase (ALK) Inhibitors with Potential Utility for the Treatment of Cancer

✍ Lewis, Richard T.; Bode, Christiane M.; Choquette, Deborah M.; Potashman, Michel 📂 Article 📅 2012 🏛 American Chemical Society 🌐 English ⚖ 594 KB